SCHEMBL18333437

SCHEMBL18333437

O=C([C@@H]1CCCO1)N1CCC(F)(Cc2ccc(-c3cnc4ccccc4c3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.46
▸ FASN P49327 4/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.43
▸ HTT P42858 1/20 0.43
▸ RECQL P46063 1/20 0.42
▸ CYP3A4 P08684 1/20 0.41
▸ LMNA P02545 2/20 0.41
▸ PARP1 P09874 1/20 0.41
▸ TSHR P16473 2/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ MAPT P10636 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18321366 1.00 ALDH1A1 (0.46) ALDH1A1FASNL3MBTL1KDM4EHTT
SCHEMBL18321509 1.00 ALDH1A1 (0.46) ALDH1A1FASNL3MBTL1KDM4EHTT
SCHEMBL31696891 1.00 ALDH1A1 (0.46) ALDH1A1FASNL3MBTL1KDM4EHTT
SCHEMBL18321467 0.86 FASN (0.53) ALDH1A1FASN
SCHEMBL18321389 0.85 ALDH1A1 (0.45) ALDH1A1FASNL3MBTL1KDM4EHTT
SCHEMBL31696903 0.85 ALDH1A1 (0.45) ALDH1A1FASNL3MBTL1KDM4EHTT
SCHEMBL18321386 0.85 ALDH1A1 (0.45) ALDH1A1FASNL3MBTL1KDM4EHTT
SCHEMBL21651719 0.84 FAAH (0.52) ALDH1A1FASNKDM4EHTTPARP1
SCHEMBL18333369 0.84 FAAH (0.52) ALDH1A1FASNKDM4EHTTPARP1
SCHEMBL18321573 0.82 ALDH1A1 (0.44) ALDH1A1FASNL3MBTL1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919875-B2 Substituted 4-benzyl and 4-benzoyl piperidine derivatives 89BIO LTD (IL) 2021-02-16 — — US disclosed
EP-3310773-B1 SUBSTITUTED 4-BENZYL AND 4-BENZOYL PIPERIDINE DERIVATIVES 89BIO LTD (IL) 2020-12-02 — — EP disclosed
US-20200031797-A1 SUBSTITUTED 4-BENZYL AND 4-BENZOYL PIPERIDINE DERIVATIVES CEPHALON LLC 2020-01-30 — — US disclosed
WO-2016205590-A1 SUBSTITUTED 4-BENZYL AND 4-BENZOYL PIPERIDINE DERIVATIVES CEPHALON, INC. (US) 2016-12-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200031797-A1 SUBSTITUTED 4-BENZYL AND 4-BENZOYL PIPERIDINE DERIVATIVES FASN, FADS1, ASS1 ALDH1A1 170/4885FASN 1/4885L3MBTL1 4479/4885
US-10919875-B2 Substituted 4-benzyl and 4-benzoyl piperidine derivatives FASN, CES1, FADS2 ALDH1A1 149/4885FASN 1/4885L3MBTL1 4430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback